- Home
- EA vs IQV Comparison
EA vs IQV Comparison
Compare EA & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EA
- IQV
- Stock Information
- Founded
- EA 1982
- IQV 1982
- Country
- EA United States
- IQV United States
- Employees
- EA N/A
- IQV N/A
- Industry
- EA Computer Software: Prepackaged Software
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EA Technology
- IQV Health Care
- Exchange
- EA Nasdaq
- IQV Nasdaq
- Market Cap
- EA 36.5B
- IQV 31.6B
- IPO Year
- EA N/A
- IQV 2013
- Fundamental
- Price
- EA $144.25
- IQV $177.31
- Analyst Decision
- EA Buy
- IQV Strong Buy
- Analyst Count
- EA 20
- IQV 18
- Target Price
- EA $154.32
- IQV $248.72
- AVG Volume (30 Days)
- EA 3.7M
- IQV 1.5M
- Earning Date
- EA 05-06-2025
- IQV 05-01-2025
- Dividend Yield
- EA 0.53%
- IQV N/A
- EPS Growth
- EA N/A
- IQV 2.74
- EPS
- EA 3.92
- IQV 7.49
- Revenue
- EA $7,347,000,000.00
- IQV $15,405,000,000.00
- Revenue This Year
- EA N/A
- IQV $4.30
- Revenue Next Year
- EA $6.16
- IQV $6.17
- P/E Ratio
- EA $36.77
- IQV $23.68
- Revenue Growth
- EA N/A
- IQV 2.81
- 52 Week Low
- EA $115.21
- IQV $176.03
- 52 Week High
- EA $168.50
- IQV $253.84
- Technical
- Relative Strength Index (RSI)
- EA 64.23
- IQV 35.22
- Support Level
- EA $141.19
- IQV $180.00
- Resistance Level
- EA $146.41
- IQV $188.39
- Average True Range (ATR)
- EA 2.48
- IQV 4.58
- MACD
- EA 0.38
- IQV -0.35
- Stochastic Oscillator
- EA 80.39
- IQV 9.22
About EA Electronic Arts Inc.
Electronic Arts is one of the largest global developers and publishers of video games. Its most important franchises are the Madden NFL and FC soccer games, which it releases annually. In 2024, it also relaunched its American college football game. Other major franchises include Apex Legends, Battlefield, and The Sims. Typically, about three quarters of the firm's sales are from in-game spending, with the remainder coming from initial game sales.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.